Ovid Adds BioCyc Pathway/Genome Databases to Support Genomic Researchers
Wolters Kluwer aids omics efforts with one-stop access to comprehensive data for sequenced organisms WALTHAM,…
News
Enterprise Increases Quarterly Distribution
HOUSTON–(BUSINESS WIRE)–Enterprise Products Partners L.P. (NYSE: EPD) (“Enterprise”) announced today that the board of directors…
Inspur Information Named IDC Supply Chain Technology Leader
Designed for mass customization, Inspur Information’s supply chain was highly regarded for its sophistication, efficiency,…
Cacheflow Launches Product to Help Companies Get More ARR with Less Burn, And Hires Key Executives to Accelerate Growth
Cacheflow completes the tech stack for sales by closing the last loop with customers: propose,…
Crossword Cybersecurity’s Identiproof demonstrates early commitment to Open Badges V3 in the Jobs for the Future Plugfest
7 July 2022 – London, UK – Crossword Cybersecurity Plc (AIM:CCS, “Crossword”, the “Company” or…
Biora Therapeutics Announces Successful Completion of Second Device Performance Study in Human Subjects for its Targeted Therapeutics Platform
Study demonstrated device functioned as designed when administered with food, potentially enabling non-fasted administration SAN…
Michigan’s Can-Lab Joins SC Labs National Cannabis and Hemp Testing Network
Scientific expertise and financial strength will be a boost for the Michigan cannabis market SANTA…
Alvotech Initiates Patient Study for AVT06, a Proposed Biosimilar for Eylea®
AVT06 is the third biosimilar candidate developed by Alvotech to enter clinical studies Eylea® (aflibercept)…
SciSparc’s JV MitoCareX Bio Launches its Advanced New Laboratory Facility
The new facility will serve the JV’s development of potential cancer drugs TEL AVIV, Israel,…
Tempest to Participate in Panel Discussion at 2022 William Blair Biotech Focus Conference
President Tom Dubensky, Ph.D., to Share Expertise on Next Generation Immuno-Oncolgy Targets SOUTH SAN FRANCISCO, Calif.,…
Ocuphire Announces Late-Breaking Paper for Nyxol for Reversal of Dilation Indication at Annual ASRS Meeting and Five More Presentations at Conferences in July
Mina Sooch CEO to Present at Ophthalmic Innovation Panel at the 11th Annual AECOS Summer…
AGTC to Present at Upcoming American Society of Retina Specialists Annual Meeting
July 7, 2022 at 8:00 AM EDT GAINESVILLE, Fla., and CAMBRIDGE, Mass., July 07, 2022 (GLOBE…
Radius Announces First Patient Randomized in the RAD011 Pivotal Trial for Prader-Willi Syndrome
Advances asset in the neuro-endocrine orphan disease space SCOUT-015 clinical trial currently has 9 activated…
Humacyte Hosting Key Opinion Leader Webinar on Human Acellular Vessels™ in the Treatment of Vascular Trauma
Thursday, July 14, 2022 @ 11:30 a.m. ET DURHAM, N.C., July 07, 2022 (GLOBE NEWSWIRE)…
Akari Therapeutics Announces First Patient to Complete Course of Treatment in the Phase III Part A Clinical Trial of Investigational Nomacopan in Pediatric Hematopoietic Stem Cell Transplant-Related Thrombotic Microangiopathy (HSCT-TMA)
NEW YORK and LONDON, July 07, 2022 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX),…
Eyenovia Announces Appointments of Dr. Ellen Strahlman and Dr. Ram Palanki as New and Independent Members of its Board of Directors
NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) — Eyenovia, Inc. (Nasdaq: EYEN), an ophthalmic pharmaceutical…
IgA Nephropathy Takes Center Stage with Various Patient and Payer Events in July
NEW YORK, July 07, 2022 (GLOBE NEWSWIRE) — As part of its ongoing commitment to…
Longeveron Announces Abstract Accepted for Presentation at the Alzheimer’s Association International Conference (AAIC)
MIAMI, July 07, 2022 (GLOBE NEWSWIRE) — Longeveron Inc. (NASDAQ: LGVN), a clinical stage biotechnology company…
Arch Therapeutics Raises Approximately $3.5 Million in Convertible Note Financing
Uplisting is the Next Significant Step FRAMINGHAM, Mass., July 07, 2022 (GLOBE NEWSWIRE) — Arch…
SELLAS Life Sciences Adds Once-a-Week Dose Cohort in Ongoing Phase 1 Clinical Trial with its Highly Selective CDK9 Inhibitor GFH009
The Company Continues to Evaluate Optimal Dosing for Patients with Acute Myeloid Leukemia and Lymphoma…